Organ Preservation Solution Market Growth Report | 2023-2028

Organ Preservation Solution Market Forecast to 2028 - Global Analysis By Type [University of Wisconsin Solution (UW), Custodiol HTK, Perfadex, Hypothermosol, and Others], Application (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others), Organ Type (Kidneys, Liver, Lungs, Heart, and Others), and End User (Organ Transplant Centers, Hospitals, and Specialty Clinics)

Publication Month : May 2023

  • Report Code : TIPHE100001100
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 211
Inquire Before Buy

PRICING

$4550

$3640

[Research Report] The organ preservation solution market was valued at was valued at US$ 255.91 million in 2022 and is expected to reach US$ 399.49 million by 2028; it is estimated to register a CAGR of 7.8% from 2023 to 2028.

Organ preservation solutions are used to protect organs prior to transplantation because organs in the outer environment often collapse once removed from the human body. Organ conservation plans are implemented to save and maintain the value of organs for future applications such as transplantation and research. The development of organ preservation technologies is expected to be fueled by growing interest in organ transplantation procedures across the globe. Similarly, developing mechanically propelled techniques for saving organs support the organ preservation solution market growth.

The organ preservation solution market is segmented on the basis of type, application, organ type, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing parameters such as market trends, technological advancements, and market dynamics, along with the competitive landscape analysis of the leading market players across the world. 

Organ Preservation Solution Market - 

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Organ Preservation Solution Market: Strategic Insights

organ-preservation-market
Market Size Value inUS$ 255.91 million in 2022
Market Size Value byUS$ 399.49 million by 2028
Growth rateCAGR of 7.8% from 2023 to 2028
Forecast Period2023-2028
Base Year2022
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Lucrative Regions for Organ Preservation Solution Market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Market Insights – Organ Preservation Solution Market

Increasing Prevalence of Chronic Diseases Leading to Kidney Failure Drives Organ Preservation Solution Market

A kidney transplant is the most common organ transplant in the world. According to the Organ Procurement and Transplantation Network (OPTN), in 2021, 41,354 organ transplants were performed in the US, an increase of 5.9% over 2020. There was a total of 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplants. As per the Health Resources and Services Administration (HRSA), in 2022, over 88,901 patients were registered on the kidney waiting list. Approximately 21 individuals die every day while waiting for organ transplantation, while over 120,000 men, women, and children seek life-saving organ transplantation.

Chronic kidney disease (CKD) is a common and potentially fatal condition that affects approximately one in every ten people worldwide. Additionally, a study published by the National Kidney Foundation in 2020 predicted that approximately 35.0% of the diabetic population over the age of 20 would develop chronic kidney disease over time. The National Kidney Foundation reported that CKD is expected to kill more people in 2021 than prostate or breast cancer. It is a widely under-recognized emergency health condition. Further, 1 in every 3 American adults (approximately 80 million people) is at risk of developing chronic kidney disease.

According to the estimates by the Centers for Disease Control and Prevention (CDC) in 2020, 1 in 3 adults with diabetes and 1 in 5 adults with high blood pressure might have chronic kidney disease. Per the CDC report issued in 2021, ~15% of people in the US suffer from chronic renal disease each year. Moreover, the National Kidney Foundation states that ~90% of people with kidney damage are not aware of having chronic kidney disease, which indicates the underlying market perspective for kidney diseases. These factors are expected to support the organ preservation solution market growth during the forecast period.

Organ Type Insights

Based on organ type, the global organ preservation solution market is segmented into heart, lung, kidney, liver, and others. The kidney segment held the largest share of the market in 2022. However, the heart segment is estimated to register the highest CAGR of 8.3% in the market during the forecast period. The increasing number of kidney transplant procedures and cases of kidney failure across the globe are the major factors influencing the segment growth. According to a 2021 Centers for Disease Control and Prevention (CDC) report, more than 1 in 7, or 15% of adults or approximately 37 million patients in the US suffer from chronic kidney disease each year, with ~786,000 suffering from end-stage renal disease (ESRD). Various awareness campaigns promoting the benefits of kidney transplantation are also expected to drive the segment growth. For example, in September 2022, UHN’s Ajmera Transplant Centre and The Centre for Living Organ Donation announced the launch of a new campaign, Great Actions Leave a Mark. The campaign showcased the stories and scars of 39 living organ donors and transplant recipients across Canada. This was aimed to highlight the beautiful gift of life that is given when a kidney or liver donor donates their organ to save the life of another and encourages more Canadians to get involved. Similarly, the NHS launched the “Advancing American Kidney Health” Initiative with the goal of improving the lives of patients suffering from kidney disease in the US. Kidney transplantation was dominated by an increased incidence of kidney disease, as the rate of renal failure was high.

Organ Preservation Solution Market, by Organ Type – 2022 and 2028

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Companies are investing in the development of new and innovative instruments to secure a good return on investment (ROI). Additionally, product approval by regulatory authorities confirms the reliability and credibility of new age control units and sanitized workstations. Recently, various market players have launched high-end and top-quality organ preservation solutions and adopted several strategies. A few strategies by market players are listed below:

  • In August 2022, Paragonix Technologies, Inc. announced a significant milestone of preserving over 2,000 donor organs while also providing transplant hospitals with Advanced Organ Preservation (AOPT) technology and a statewide clinical support network. Each of these technologies employs first-of-their-kind preservation methods and has proven to improve conventional “ice and cooler” practices significantly.
  • In June 2022, Paragonix Technologies, Inc. expanded the adoption of its LIVERguard Donor Liver Preservation System at the 2022 American Transplant Congress in Boston, Massachusetts. Since the commercial introduction of the LIVERguard system in January 2022, the advanced donor organ preservation system has been utilized at 8 transplant centers in the US, including UF Health Shands, one of the largest liver transplant centers in the world. Paragonix has also been partnering with numerous Organ Procurement Organizations to provide more access to this unique hypothermic preservation technology.
  • In April 2022, TransMedics Group, Inc. received premarket US Food and Drug Administration (FDA) approval of its OCS Heart System for use with organs from donors after circulatory death (DCD). The OCS Heart System is now approved with the extended clinical indication for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death (DCD) hearts.

These recent developments enhance the mode of performing experiments in large and medium-sized laboratories that work with cell cultures. The mounting number of novel product launches and approvals and acquisitions facilitates the organ preservation solution market growth.

Organ Preservation Solution – Market Segmentation

The global organ preservation solution market is segmented on the basis of type, application, organ type, and end user. Based on type, the market is segmented into University of Wisconsin solution (UW), Custodiol HTKs, perfadix, hyperthermosol, and others. Based on applicaton, the market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. Based on organ type, the market is segmented into into heart, lung, kidney, liver, and others. Based on end user, the market is segmented into organ transplant centers, hospitals, and specialty clinics.

Based on geography, the organ preservation solution market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Company Profiles – Organ Preservation Solution Market

  • Waters Medical Systems LLC
  • XVIVO Perfusion
  • TransMedics
  • OrganOx Limited
  • Paragonix Technologies, Inc
  • Dr. Franz Koehler Chemie GmbH
  • Accord Healthcare
  • 21ST CENTURY MEDICINE
  • Shanghai Genext Pharmaceutical Technology
  • Bridge to Life Ltd
  • Preservation Solutions, Inc.
  • Lifeline Scientific
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Type, Application, Organ Type, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the key players in the organ preservation solution market?

Waters Medical Systems LLC, XVIVO Perfusion, TransMedics, OrganOx Limited, Paragonix Technologies, Inc, Dr. Franz Koehler Chemie GmbH, Accord Healthcare, 21ST CENTURY MEDICINE, Shanghai Genext Pharmaceutical Technology, and Bridge to Life Ltd, Perfusion Solutions, Lifeline Scientific Inc. among others are among the leading companies operating in the organ preservation solution market.

Which type segment led the organ preservation solution market?

Based on type, University of Wisconsin solution (UW), segment held the largest market share of the organ preservation solution market in 2022 and hyperthermosol segment is anticipated to register the highest CAGR during the forecast period.

What is organ preservation solution?

Organ preservation solutions are used to protect organs prior to transplantation because organs in the outer environment often collapse once removed from the human body. Organ conservation plans are implemented to save and maintain the value of organs for future applications such as transplantation and research. The development of organ preservation technologies is expected to be fueled by growing interest in organ transplantation procedures across the globe. Similarly, developing mechanically propelled techniques for saving organs support the market growth for organ preservation solutions.

What is the regional market scenario of the organ preservation solution market?

Global organ preservation solution market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America held the largest market share of the organ preservation solution market in 2022 and is expected to retain its dominance during the forecast period.

What are the driving factors for the organ preservation solution market across the globe?

Rising need for organ transplantation, increasing prevalence of chronic diseases leading to kidney failure, rising geriatric population are the key driving factors for the organ preservation solution market.

Which end user segment held the largest market share in the organ preservation solution market?

Based on end user, the organ transplant centers segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR in the market during the forecast period.

Which application segment held the largest market share in the organ preservation solution market?

Based on the application, the static cold storage segment held the largest market share of the organ preservation solution market in 2022, and normothermic machine perfusion is anticipated to register the highest CAGR during the forecast period.

The List of Companies - Organ Preservation Solutions Market

  1. Waters Medical Systems LLC
  2. XVIVO Perfusion
  3. TransMedics
  4. OrganOx Limited
  5. Paragonix Technologies, Inc
  6. Dr. Franz Koehler Chemie GmbH
  7. Accord Healthcare
  8. 21ST CENTURY MEDICINE
  9. Shanghai Genext Pharmaceutical Technology
  10. Bridge to Life Ltd
  11. Perfusion Solutions, Inc.
  12. Lifeline Scientific Inc.   

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Organ Preservation Solution Market